Alexandrosz Czira

14PUBLICATIONS
33CO-AUTHORS
Regenerative medicine (incl. stem cells)Toxicology (incl. clinical toxicology)Environmental epidemiologyOtorhinolaryngologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 21, 2024
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.

Kieran J Rothnie, Robert P Wood, Alexandrosz Czira

|Apr 22, 2024
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.

Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen

|Apr 02, 2024
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Afisi S Ismaila, Kieran J Rothnie, Robert P Wood

|Feb 07, 2024
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study.

Alexandrosz Czira, Victoria Banks, Gema Requena

|Dec 13, 2023
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.

Alexandrosz Czira, Shoko Akiyama, Takeo Ishii

|Sep 25, 2023
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Afisi S Ismaila, Kieran J Rothnie, Robert P Wood

Pageof 3

Frequent Collaborators

14 joint publications

Afisi S Ismaila

12 joint publications

Chris Compton

11 joint publications

Robert Wood

10 joint publications

Kieran J Rothnie